| Cardiovascular Risk Factors, Body Composition, Fitness Levels And Quality Of Life In Overweight And Obese 8-17 Year Olds (NCT02024399) | Stony Brook University | 2004-08-01 |
| Biochemical and Genetic Markers of Hypertension in Women (NCT00090467) | Brigham and Women's Hospital | 2004-08-01 |
| Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension (NCT00759551) | Takeda | 2004-08-01 |
| Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions (NCT01216852) | Roxane Laboratories | 2004-08-01 |
| To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure. (NCT00170924) | Novartis | 2004-08-01 |
| Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care (NCT00291824) | Caroline Medical Group | 2004-08-01 |
| SPP100 Dose Finding Study in Japan (NCT00311012) | Novartis | 2004-08-01 |
| Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension. (NCT00219024) | Novartis | 2004-08-01 |
| Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients (NCT00357955) | Providence VA Medical Center | 2004-08-01 |
| Mutation Analysis of 17α-Hydroxylase (NCT00172510) | National Taiwan University Hospital | 2004-08-01 |
| VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women (NCT00171132) | Novartis | 2004-08-01 |
| The Relaxation and Blood Pressure in Pregnancy (REBIP) Study (NCT00303173) | University of Toronto | 2004-08-01 |
| AMISH : Aprovel for Management of Isolated Systolic Hypertension (NCT00264212) | Sanofi | 2004-08-01 |
| Preventing Heart Disease in Underserved Patients (NCT00778804) | Temple University | 2004-07-01 |
| A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure (NCT00171353) | Novartis | 2004-07-01 |
| Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction (NCT00171327) | Novartis | 2004-07-01 |
| VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria (NCT00171067) | Novartis | 2004-07-01 |
| Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension (NCT00139555) | Novartis | 2004-07-01 |
| Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (NCT00150384) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-07-01 |
| Treatment Targets for Chronic Hypertension in Pregnancy (NCT00194974) | Weill Medical College of Cornell University | 2004-07-01 |
| A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril. (NCT00171366) | Novartis | 2004-07-01 |
| Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus (NCT00982358) | Charite University, Berlin, Germany | 2004-07-01 |
| Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension (NCT00219037) | Novartis | 2004-06-01 |
| Rehabilitation in Primary Care: A Project to Maximize the Health Status of Adults With Chronic Illness (NCT00229957) | Hamilton Health Sciences Corporation | 2004-06-01 |
| Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes (NCT00123604) | St. Paul Heart Clinic | 2004-06-01 |
| Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension (NCT00235001) | Abbott | 2004-06-01 |
| Population Based Strategies for Effective Control of High Blood Pressure in Pakistan (NCT00327574) | Aga Khan University | 2004-06-01 |
| Federal Study of Adherence to Medications in the Elderly (FAME) (NCT00393419) | Walter Reed Army Medical Center | 2004-06-01 |
| LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects. (NCT00167869) | Wageningen University | 2004-06-01 |
| Comparison of Two Treatment Strategies in Hypertensive Patients (NCT00171444) | Novartis | 2004-06-01 |
| 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension (NCT00153049) | Boehringer Ingelheim | 2004-06-01 |
| Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP) (NCT00093912) | The Medicines Company | 2004-06-01 |
| Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients. (NCT00171756) | Novartis | 2004-06-01 |
| A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs (NCT00364026) | Gilead Sciences | 2004-06-01 |
| Computer-Assisted Cancer Risk Behavior Counseling (NCT00242645) | Thomas Jefferson University | 2004-06-01 |
| Genetics and Cardiovascular Reactivity in Young Twins (NCT00083850) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-06-01 |
| Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime Sleepiness (NCT00127348) | Sociedad Española de Neumología y Cirugía Torácica | 2004-05-01 |
| China Salt Substitute Study (NCT00145756) | The George Institute | 2004-05-01 |
| Exercise Training in Type 2 Diabetes and Hypertension (NCT00212303) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-05-01 |
| Urinary Concentration and Diluting Ability in Patients With Chronic Renal Disease and/ or Hypertension (NCT00313430) | Erling Bjerregaard Pedersen | 2004-05-01 |
| Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients (NCT00160498) | UCB Pharma | 2004-05-01 |
| Impact of an IT-Based and Healthcare Professional Support Program on Patients With High Blood Pressure (NCT00374829) | Université de Montréal | 2004-05-01 |
| Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline (NCT00126516) | Nara Medical University | 2004-05-01 |
| Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC) (NCT00093925) | The Medicines Company | 2004-05-01 |
| Dietary Fiber and Cardiovascular Inflammatory Markers (NCT00085800) | Medical University of South Carolina | 2004-05-01 |
| Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels (NCT00143234) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-05-01 |
| A Comparison of Telemedical and Conventional Antihypertensive Treatment (NCT00282334) | Regional Hospital Holstebro | 2004-05-01 |
| Salt Reduction on Blood Pressure and Cardiovascular Organ Damage (NCT00152074) | St George's, University of London | 2004-04-01 |
| Diuretics In the Management of Essential Hypertension (DIME) Study (NCT00131846) | Kyoto University | 2004-04-01 |
| VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis (NCT00171080) | Novartis | 2004-04-01 |
| A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension (NCT00170976) | Novartis | 2004-04-01 |
| Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306) (NCT00953680) | Organon and Co | 2004-04-01 |
| Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG) (NCT00093886) | The Medicines Company | 2004-04-01 |
| Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions (NCT00602017) | Roxane Laboratories | 2004-04-01 |
| The Renin-Angiotensin System in Essential Hypertension (NCT00141583) | St George's, University of London | 2004-04-01 |
| Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes (NCT00241124) | Novartis | 2004-04-01 |
| Haemodialysis Salt Reduction Study (NCT00141609) | St George's, University of London | 2004-04-01 |
| Bioequivalency Study of Amlodipine Tablets Under Fed Conditions (NCT00601302) | Roxane Laboratories | 2004-04-01 |
| Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women (NCT00102141) | Bayer | 2004-04-01 |
| Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL) (NCT00233532) | Abbott | 2004-03-01 |
| Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension (NCT00333489) | Novartis | 2004-03-01 |
| Effect of Regular Sildenafil on Blood Pressure and Arterial Function in Hypertension (NCT00317421) | University of Edinburgh | 2004-03-01 |
| A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension (NCT00133185) | Boehringer Ingelheim | 2004-03-01 |
| RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment (NCT00258921) | Sanofi | 2004-03-01 |
| Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes (NCT00738023) | Emory University | 2004-03-01 |
| Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes (NCT00419484) | Dokkyo Medical University | 2004-03-01 |
| Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) (NCT00234858) | Abbott | 2004-03-01 |
| Physical Therapy for Hypertensive Elderly (NCT00611364) | Universidade Federal de Goias | 2004-03-01 |
| Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension (NCT01518855) | Bayer | 2004-03-01 |
| Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA) (NCT00089713) | Synvista Therapeutics, Inc | 2004-03-01 |
| An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension (NCT00185068) | Daiichi Sankyo | 2004-03-01 |
| Group Visits to Improve Hypertension Management (NCT00129493) | US Department of Veterans Affairs | 2004-02-01 |
| Hypertension and Cardiovascular Risk Factors (NCT00171782) | Novartis | 2004-02-01 |
| A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin (NCT00185094) | Daiichi Sankyo | 2004-02-01 |
| Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence (NCT00201149) | Boston Medical Center | 2004-02-01 |
| A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients (NCT00248937) | Weill Medical College of Cornell University | 2004-02-01 |
| Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics (NCT00157638) | Hamilton Health Sciences Corporation | 2004-02-01 |
| Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk (NCT00201136) | Duke University | 2004-02-01 |
| Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) (NCT00234871) | Abbott | 2004-01-01 |
| Improving Practice Patterns for the Treatment of Hypertension (NCT00265044) | US Department of Veterans Affairs | 2004-01-01 |
| Nebivolol Versus Carvedilol in Patients With Heart Failure (NCT00511888) | IRCCS San Raffaele | 2004-01-01 |
| HYPGENE-Genetics Fitness Obesity & Risk of Hypertension (NCT00083811) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-01-01 |
| Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1) (NCT00093249) | The Medicines Company | 2004-01-01 |
| Longitudinal Cardiac Outcomes and Body Composition (NCT00081692) | Virginia Commonwealth University | 2004-01-01 |
| A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril (NCT00171119) | Novartis Pharmaceuticals | 2004-01-01 |
| Effective Endurance Training in Metabolic Syndrome (NCT00218998) | Norwegian University of Science and Technology | 2004-01-01 |
| Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP) (NCT00154271) | Novartis | 2004-01-01 |
| IV Double and Triple Concentrated Nicardipine for Stroke and ICH (NCT00325793) | OSF Healthcare System | 2004-01-01 |
| Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients (NCT00409643) | Novartis | 2004-01-01 |
| Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria (NCT00561964) | Sanofi | 2004-01-01 |
| Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) (NCT00149227) | Kyoto Prefectural University of Medicine | 2004-01-01 |
| Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients (NCT00729963) | Laval University | 2004-01-01 |
| The Effects of Metformin on Blood Vessel Structure and Function (NCT00105066) | National Institute on Aging (NIA) | 2004-01-01 |
| Improving Diabetes in Primary Care (IMPACT) (NCT00108927) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-12-01 |
| Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension (NCT00672113) | Bayer | 2003-12-01 |
| Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. (NCT00232882) | Institut de Recherches Cliniques de Montreal | 2003-12-01 |
| A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension (NCT00241007) | Novartis | 2003-12-01 |
| Rationale and Design for Shiga Microalbuminuria Reduction Trial (NCT00202618) | Shiga University | 2003-12-01 |
| Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2) (NCT00093262) | The Medicines Company | 2003-12-01 |
| Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population (NCT00847834) | Sanofi | 2003-12-01 |